Heart rhythm disorder may reshape valve before leaks start
NCT ID NCT07617974
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study uses 3D echocardiography to track changes in the tricuspid valve of 66 people with atrial fibrillation (AF) who do not yet have significant valve leakage. Researchers want to see if the valve's shape changes as AF becomes more persistent. The goal is to better understand how AF can lead to tricuspid regurgitation over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors predict which AF patients are at risk for tricuspid regurgitation, potentially guiding earlier treatment.
- What could go wrong
- This is a small observational study, not a treatment trial. It only measures changes and cannot prove cause-and-effect or lead directly to new therapies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centro Cardiologico Monzino; IRCCS
RECRUITINGMilan, Milan, 20133, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a smartphone alert replace daily blood thinners for AF?
- A tiny neck implant could catch Stroke-Causing clots before they reach the brain
- Blood fat clues could flag hidden heart rhythm risk
- Could a new injection tame atrial fibrillation?
- Can a new heart ablation technique work without x-rays?
- Which blood thinner is safer for heart patients? a Head-to-Head test